Sign in

CIK 0001395937

  • Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320162505
Phone
+1 781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-04 Huber Martin H. Jr. Director Grant or award +24,000 103,000
2025-05-19 Huber Martin H. Jr. Director Purchase +5,000 $8.99 $45K 79,000
2025-02-05 Huber Martin H. Jr. Director Grant or award +25,000 74,000
2024-02-07 Huber Martin H. Jr. Director Grant or award +17,000 49,000
2023-02-02 Huber Martin H. Jr. Director Grant or award +16,000 32,000
2022-02-02 Huber Martin H. Jr. Director Grant or award +16,000 16,000
2021-09-15 Huber Martin H. Jr. Director Grant or award · Stock Options (Right to buy) +35,000 $19.36 $678K 35,000

Page 1 of 1 · 7 trades